<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03684486</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/11/0087</org_study_id>
    <nct_id>NCT03684486</nct_id>
  </id_info>
  <brief_title>Rehabilitation by Effort for Patients With Advanced Bronchial Cancer</brief_title>
  <acronym>RehabKBP</acronym>
  <official_title>Rehabilitation by Effort for Patients With Advanced Bronchial Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Bronchopulmonary cancers or mesothelioma are associated with effort deconditioning due to
      pathology (chronic inflammation) and also to treatments (surgery, radiotherapy,
      chemotherapy); it's considerably alters patients quality of life.

      Investigators want to ensured the feasibility of rehabilitation by effort for these patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2012</start_date>
  <completion_date type="Anticipated">February 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patients who completed at least 6 sessions of rehabilitation</measure>
    <time_frame>10 years</time_frame>
    <description>number of patients who completed at least 6 sessions of rehabilitation by effort</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Bronchial Cancer</condition>
  <condition>Malignant Mesothelioma</condition>
  <arm_group>
    <arm_group_label>rehabilitation by effort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>8 sessions of rehabilitation by effort in sports medicine</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>rehabilitation by effort</intervention_name>
    <arm_group_label>rehabilitation by effort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  General condition according to World Health Organisation 0-1

          -  Age between 18 and 70 years old

          -  Non progressive patients according to RECIST criteria 1.1 after chemotherapy treatment
             whichever line of treatment

          -  Autonomous patient

          -  Voluntary written informed consent signed

          -  Patients with social security insurance

        Exclusion Criteria:

          -  Bone metastasis with fracture risk

          -  Significant cardiovascular pathology

          -  Cardiac, vascular, rheumatologic or neurologic contraindication

          -  Patients living far 60 kms from Toulouse

          -  Patients under juridical protection guardianship, or tutelage measure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julien Mazi√®res, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julien MAZIERES, MD PhD</last_name>
    <phone>05 67 77 18 37</phone>
    <phone_ext>+33</phone_ext>
    <email>mazieres.j@chu-toulouse.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU de Toulouse</name>
      <address>
        <city>Toulouse</city>
        <zip>31059</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Julien MAZIERES, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>September 24, 2018</study_first_submitted>
  <study_first_submitted_qc>September 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">September 25, 2018</study_first_posted>
  <last_update_submitted>April 16, 2019</last_update_submitted>
  <last_update_submitted_qc>April 16, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>bronchial cancer</keyword>
  <keyword>rehabilitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mesothelioma</mesh_term>
    <mesh_term>Carcinoma, Bronchogenic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

